China Universal Asset Management Company’s Jyong Biotech MENS Stock Holding History

China Universal Asset Management Company’s Portfolio MENS Stock Details MENS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$25K	Sell	12,100 -1,073	-8%	-$2.28K	﹤0.01%	492
2026 Q1	$28.3K	Buy	13,173 +784	+6%	+$1.92K	﹤0.01%	484
2025 Q4	$48.9K	Buy	+12,389	New	+$438K	﹤0.01%	454

Other funds holding MENS

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

China Universal Asset Management Company's MENS Position: Q2 2026 in Review

China Universal Asset Management Company reduced its Jyong Biotech (MENS) stake by 8.1% in Q2 2026, selling an estimated $2.28K and leaving 12,100 shares worth $25K. The position accounts for ﹤0.01% of the portfolio, ranked #492.

China Universal Asset Management Company first reported a position in MENS in Q4 2025 and has held it in 3 quarters since. The position peaked at $48.9K in Q4 2025. 2 funds tracked by Wall St. Rank hold MENS as of Q2 2026.

China Universal Asset Management Company held 12,100 shares of Jyong Biotech worth $25K as of Q2 2026.
China Universal Asset Management Company sold 1,073 Jyong Biotech shares in Q2 2026, an estimated $2.28K.
Jyong Biotech made up ﹤0.01% of China Universal Asset Management Company's portfolio in Q2 2026, its #492 holding.
China Universal Asset Management Company first reported a position in Jyong Biotech in Q4 2025 and has held it in 3 quarters since.
China Universal Asset Management Company's Jyong Biotech position peaked at $48.9K in Q4 2025.
2 funds tracked by Wall St. Rank held Jyong Biotech as of Q2 2026.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.